The PI3K Pathway in Human Disease
Clicks: 226
ID: 119730
2017
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
3.6
/100
12 views
12 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Phosphoinositide 3-kinase (PI3K) activity is stimulated by diverse oncogenes and growth factor receptors, and elevated PI3K signaling is considered a hallmark of cancer. Many PI3K pathway-targeted therapies have been tested in oncology trials, resulting in regulatory approval of one isoform-selectiv …
| Reference Key |
da2017cellthe
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Fruman DA;Chiu H;Hopkins BD;Bagrodia S;Cantley LC;Abraham RT;; |
| Journal | Cell |
| Year | 2017 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
signal transduction*
neoplasms / drug therapy
neoplasms / pathology
neoplasms / metabolism
pmid:28802037
pmc5726441
doi:10.1016/j.cell.2017.07.029
david a fruman
honyin chiu
robert t abraham
cell physiological phenomena
immune system / metabolism
phosphatidylinositol 3-kinases / metabolism*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.